Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in F... (ets on this basis. -- Non-GAAP ...)

Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009

Date:5/1/2008

ets on this

basis.

-- Non-GAAP Net Income and Earnings Per Share

The use of these non-GAAP measures allows management to monitor the

level of net income and earnings per share excluding both the costs of

our business transformation, in-process research and development costs,

as well as any related tax effects, and the favorable resolution of an

audit of prior year tax returns. We establish our budgets, forecasts,

and performance targets on this basis. Reconciliation of Non-GAAP Measures for the Fourth Quarter FY08 and FY07

03/29/08 03/31/07

Non-GAAP S,G&A

GAAP S,G&A $44,042 $31,815

Restructuring Costs (2,384) (586)

Non-GAAP S,G&A $41,658 $31,229

Non-GAAP Operating expenses

GAAP Operating Expenses $49,832 $32,655

Restructuring Costs (2,384) (586)

Baxter PI Settlement 5,700

Non-GAAP Operating Expenses $47,448 $37,769

Non-GAAP Operating income

GAAP Operating Income $20,309 $25,691

Restructuring Costs 2,384 586

Baxter PI Settlement (5,700)

Non-GAAP Operating income $22,693 $20,577

Non-GAAP Income before taxes

GAAP Income before taxes $21,382 $28,415

Restructuring Costs 2,384 586

Baxter PI Settlement (5,700)

Non-GAAP Income before taxes $23
'/>"/>

Post Your Comments:

Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in F...(ets on this basis. -- Non-GAAP ...),Health